Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions

Carcinoma, Non-small-cell Lung

Interventions

DRUG

TLK286 in combination with docetaxel

Trial Locations (4)

Indiana University Cancer Center, Indianapolis

M.D. Anderson Cancer Center, Houston

Cancer Institute Medical Group, Los Angeles

UCLA Medical Center, Los Angeles